Osiris Therapeutics Revenue

Biotechnology Research • United States • 101-200 Employees

Osiris Therapeutics revenue & valuation

Annual revenue	$150,000,000
Revenue per employee	$968,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$480,000,000
Total funding	No funding

Key Contacts at Osiris Therapeutics

Paul Armstrong

Regional Business Director

Alfred E. Seidel

Ceo

Eloà Viera

Chief Executive Officer

Gilbert Ndolo

Executive Director

Rod Monroy

Sr Director

Osman Ateş

Center Director

Devon Sharon

Director Of Operations

Company overview

Headquarters	United States
Phone number	+14435451800
Website	osiris.com
NAICS	541714
SIC	283
Employees	101-200
Socials

Osiris Therapeutics Email Formats

Osiris Therapeutics uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 51.3% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	51.3%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	21.8%
{first name}@company.com	john@company.com	11.2%
{last name}.{first name}@company.com	doe.john@company.com	9.1%
{first name}_{last name}@company.com	john_doe@company.com	6.6%

About Osiris Therapeutics

Osiris Therapeutics, Inc. was founded in 1992 based on stem cell technology discovered by researchers at Case Western Reserve University led by Dr. Arnold Caplan. He recognized this technology had tremendous therapeutic potential. Today, more than two decades after the journey began, Osiris continues to advance the science of cellular regenerative medicine to treat patients in need. Osiris Therapeutics, based in Columbia, Maryland, is the world leader in researching, developing and marketing regenerative medicine products. Having developed the world’s first approved stem cell drug, the company continues to advance its research and development in biotechnology by focusing on innovation in regenerative medicine – including bioengineering, stem cell research and viable tissue based products. Osiris has achieved commercial success with products in orthopaedics, sports medicine and wound care, including BIO4™, Cartiform® and Grafix®. Osiris, Grafix, and Cartiform are registered trademarks of Osiris Therapeutics, Inc. BIO4 is a trademark of Stryker Corporation (NYSE: SYK). More information can be found on the company's website, www.Osiris.com.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Entry

Manager

Senior

Employees by Department

Osiris Therapeutics has 75 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore Osiris Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2018-08-06	1	N/A

Funding Insights

Number of funding rounds

Osiris Therapeutics Tech Stack

Discover the technologies and tools that power Osiris Therapeutics's digital infrastructure, from frameworks to analytics platforms.

SiteGround

Hosting

Frequently asked questions

Osiris Therapeutics is located in US.

You can reach Osiris Therapeutics at +14435451800.

Osiris Therapeutics generates an estimated annual revenue of $150,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Osiris Therapeutics has an estimated valuation of $480,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Osiris Therapeutics has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.